Zeynep B. Zengin

Hospital Medicine

360 State St
Apt 2506
New Haven, CT 06510

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Characterization of aberrant alternative splicing landscape in patients with metastatic renal cell carcinoma.

Characterization of aberrant alternative splicing landscape in patients with metastatic renal cell carcinoma.

Journal: Journal for immunotherapy of cancer

Published: March 05, 2026

Efficacy and safety of antibody-drug conjugate combination therapy in advanced urothelial carcinoma.

Efficacy and safety of antibody-drug conjugate combination therapy in advanced urothelial carcinoma.

Journal: Frontiers in oncology

Published: July 19, 2025

Microbiome Modulation for the Treatment of Solid Neoplasms.

Microbiome Modulation for the Treatment of Solid Neoplasms.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 11, 2025

Comparative Genomic Characterization of Small Cell Carcinoma of the Bladder Compared With Urothelial Carcinoma and Small Cell Lung Carcinoma.

Comparative Genomic Characterization of Small Cell Carcinoma of the Bladder Compared With Urothelial Carcinoma and Small Cell Lung Carcinoma.

Journal: JCO precision oncology

Published: April 10, 2025

Real-Time Monitoring in Renal Cell Carcinoma With Circulating Tumor DNA: A Step Forward, But How Far?

Real-Time Monitoring in Renal Cell Carcinoma With Circulating Tumor DNA: A Step Forward, But How Far?

Journal: JCO precision oncology

Published: February 28, 2025

Renal Cell Carcinoma of Variant Histology: New Biologic Understanding Leads to Therapeutic Advances.

Renal Cell Carcinoma of Variant Histology: New Biologic Understanding Leads to Therapeutic Advances.

Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting

Published: May 22, 2024

Barriers to Clinical Trial Implementation Among Community Care Centers.

Barriers to Clinical Trial Implementation Among Community Care Centers.

Journal: JAMA network open

Published: April 29, 2024

Prevalence of Dietary Modification and Supplement Use in Patients with Metastatic Renal Cell Carcinoma Receiving Systemic Therapy.

Prevalence of Dietary Modification and Supplement Use in Patients with Metastatic Renal Cell Carcinoma Receiving Systemic Therapy.

Journal: Nutrients

Published: March 23, 2024

Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial.

Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial.

Journal: Nature medicine

Published: February 04, 2024

Impact of Synchronous versus Metachronous Metastasis on Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated with First-line Immune Checkpoint Inhibitor-based Combinations.

Impact of Synchronous versus Metachronous Metastasis on Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated with First-line Immune Checkpoint Inhibitor-based Combinations.

Journal: European urology focus

Published: January 10, 2024

Eligibility Criteria in Advanced Urothelial Cancer Clinical Trials: An Assessment of Modernization and Inclusion.

Eligibility Criteria in Advanced Urothelial Cancer Clinical Trials: An Assessment of Modernization and Inclusion.

Journal: Cancer medicine

Published: December 15, 2023

Differential Impact of SPOP Mutation in Prostate and Endometrial Cancers.

Differential Impact of SPOP Mutation in Prostate and Endometrial Cancers.

Journal: JCO precision oncology

Published: November 16, 2023

Showing 1-12 of 38

Last Updated: 09/26/2026